Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation. To subscribe to Biotech Daily click here. All articles include the company name and many have senior personnel in the headline. The easiest way to search is by using the 'find' function under 'edit' on the main toolbar. June 1, May BDI Down Pharmaxis Drags May BDI Down 3. Daily news on ASX-listed biotechnology companies.
Vanderbilt Nursing Trials Sozo At Home; Antisense Prepares Phase IIb ATL For MS IND; Osprey 3. SPECIAL SUMMER CATCH-UP EDITION. Russia Approves Pharmaxis Bronchitol For Cystic Fibrosis; Genetic Signatures Easyscreen STI Test Validation Trial.
May 3, - Budget Special Edition. SPECIAL SUMMER CATCH UP EDITION. Bionomics; Prescient Releases 4. SPECIAL SUMMER CATCH-UP EDITION: Jan 2, Special Edition. Friday May 2, Lawrence Gozlan, Nathan Drona, Dr Cauwenbergh; Bio-Melbourne Hosts Animal V Human Health Debate. Circadian; Immuron Requests Capital Raising Trading Halt; Profs Christoph Zielinski, Ursula Wiedermann Advise Imugene; Suda Appoints Dr Carol Worth Technical Manager.
Special Summer Catch Up Edition. August BDI Down 1. High Court Resolves CDPP V JM Artificial Price Questions; ARC Linkage Projects; Biotech Takes 4 Of 30 Commercialisation Australia Grants; Acrux: House Of Representatives Passes IP Amendment Bill; Mesoblast Ready For Phase II Diabetic Nephropathy Trial; Evado Launches Clinical Trial Cloud Application; GI Dynamics Appoints Al-Nozha Middle East Distributor; Fisher Funds Takes 7. US Supreme Court Myriad BRCA Gene Patent Case: High Court Reserves CDPP V JM GTG Decision; Circadian: Resonance Liver Fibrosis Trial: Bluechiip; Endo Returns Urocidin Rights To Bioniche; Prima Director Martin Rogers Sells Medical Developments; Key US Patent For Calzada Polynovo Biodegradable Polymers; Bone: Medical Developments; Cogstate Licences Cognition Test To Merck Canada; Benitec: May BDI Down 6.
Dr Ross Macdonald, Isonea; GI Dynamics Expands Commercial Team. Reva; Novogen, Marshall Edwards 2-For-1 Rights Issue; Dr Roger Aston Replaces IDT Director Dr Geoffrey Vaughan; Naomi Haydari Replaces Resonance CFO Colin McDonald; Explaining Acronyms: Novogen, Marshall Edwards IND For ME For Cancer; Michael Taylor, Peter Turvey Join Foursight; Atcor Wins US Reimbursement CPT III Code; Biotron Appoints Dr Susan Pond, Robert Thomas Directors; Psivida Appoints Heartware CEO Doug Godshall Director; Orbis Reduces To Evolution And Very Intelligent Design.
Genetic Technologies; Monash, Servier Work On G-Protein-Coupled Receptors; Sunshine Heart Trading As SHCDA; Circadian VGX Potential In Corneal Graft Rejection; Switzerland Approves Sales Of Acrux Ellavie; Nanosonics Q2 Sales Up Pharmaxis On Track For Bronchitol EU Sales, US Approval; Cathrx Has Two Quarters Cash, Just; Acuvax To Acquire Israeli Diagnostic; Balam Takes Evado Opens US Office, Appoints Maria Chiam BDM; Novogen Back In Compliance With Nasdaq.
CBio; Consegna Requests Capital Raising Trading Hal t.
Jan 22, Summer Catch-Up Edition Mayne Pharma EGM For 7. Biotech Solutions Simon Finnigan Gaoled For 10 Years. The Year In Review; Clinuvel: November BDI Down 9. Regeneus Phase II Fat Stem Cell Trial For Osteoarthritis; Immuron, Hadassah Prof Ilan: October Good For Biotech: Benitec Collaboration On Rare Muscular Dystrophy; FDA Approves Circadian VGX Cancer Trials; Novogen Considers Subsidiary Share Return, Shell Sale; Living Cell AGM For 1.
Vibrovein Shows Proof-Of-Concept; Allied AGM To Confirm Placements, Elect Directors; Directors Fight Looms At Nusep AGM. September BDI Down 4. Alchemia Claims Early Small Cell Lung Cancer Hyact Efficacy; Allied Health Requests Capital Raising Halt; WEHI: Patrys Year Data Backs PAT-SC1 For Gastric Cancer; CSL: Cortical Dynamics IPO Extended To January ; Mark Scott Ceases Entirely In IM Medical; Starpharma Appoints Zita Peach Non-Executive Director.
Sigma Aldrich Licences Healthlinx IGY Technology; GI Dynamics Launches Endobarrier In Austria; Clover Corp Revenue Up 0. QRX; Orbis Takes Profit On 1. Sep 6, GI Dynamics Lists On ASX Tomorrow, Ready For Local Sales; NZ Patent For BPH, Cortical Dynamics Brain Monitor; Prana EGM To Extend Placement, Elect Lawrence Gozlan.
Novogen NV In Vitro Active In Resistant Cancer Stem Cells; Correction: Sunshine Heart; Living Cell, Springtree Close Equity Draw Down Facility; ITL Unaudited Return To Profit; Second Nasdaq Warning Letter For Novogen; Stirling In Voluntary Administration.
Pharmaxis Resubmits Bronchitol PBS Application; Bluechiip Completes Prototype Testing; Correction: NHMRC-California Call For Grant Applications; Ellex Moves Sacramento Production To Adelaide; Tissue Therapies Pays Consultant Immune System Multiple Myeloma Trial: Response, No Toxicity; Cellestis Scheme Booklet: Agenix Hoping For China Hepatitis B Trial; Bluechiip Lists On ASX Tomorrow; Europe Rejects Sigma Objection To Healthlinx Patent; Cephalon-Chemgenex Board Changes; Antisense Requests ATL, Capital Raising Trading Halt; Optiscan Appoints Cappello To Review Business; Narhex AGM To Issue 10m Options, Elect Directors; Acuvax EGM To Issue m Shares, Ratify Placement.
April BDI Up 6. Iroko Acquires Iceutica For Nanotechnology Delivery; Bionic Ear Institute Launches Simple, Cheap Hearing Aid; Avita Says Burns Study Backs Recell; QRX Completes Phase III Comparison Trial Enrolment; Viralytics Lodges Reply To FDA Hold Letter; Nestor Takes 6. PBS Committee Knocks Back Pharmaxis Bronchitol; Heartware Patient Data: Cellestis Board Responds To Shareholders; Heartware Patient Data: Optimism Despite Funds, Federal Inertia; Circadian: March BDI Up Cephalon Offers 70c A Share For Chemgenex; Bioguide Brief: Avexa, FDA Agree ATC For HIV Path; Bioguide Brief: Study Shows Sphygmocor Good For Shock Patients.
Genera Requests Capital Raising Trading Halt. Erg Key To Blood Stem Cell Regeneration; Tamara Newing Sentenced, Freed On Genetic Techno Dealing; Bioniche: Cash Sufficient, One-Off Costs; Biomd Takes Transaction Trading Halt To Suspension; Virax Loses Director Dr Albert Ting.
TGA Approves Pharmaxis Bronchitol For Cystic Fibrosis; Correction: Stop The Gene Patent Bill; Bio-Melbourne Breakfast: All Rights Reserved Biotech Daily, PO BoxCarlton, Victoria Design by Webdesign Specialist Australia.
Perron Institute WANRI ; GI Dynamics Loses Year Director Mike Carusi; Sue MacLeman Wins Bio-Melbourne Women Leadership Award. Jun 1, May BDI Down May 25, Monash Research Leads To ACS Warning On Assay Hit Pains; Melbourne Uni: Weight Loss, HbA1c Down; Japan Patent For Regeneus Progenza Stem Cells; Noxopharm NOX66 Rare Cancers Compassionate Use, Trial; Aqsitania Uses Uscom Tspiro For Lung Transplant Monitoring; Steve Lydeamore To Replace Bionomics CFO Melanie Young; Brain Appoints Emil Vasilev Finance, Operations Director.
May 18, Sirtex Patient Meta Analysis Yields Mixed Results; Biotech Daily Comment; Victoria Partners With Shanghai Institute Of Medical Quality; Osprey: May 17, Reva Posts Positive Month Fantom Stent Data; Cardiologist Hitinder Gurm: May 15, Pharmaxis: May 10, Budget AD Scalable, Potential For Wet AMD; Rhinomed Signs Amcal, Guardian For Mute Nasal Plugs; GI Dynamics: Ricardo Cohen, Christopher Thompson Advisers.
Dr Chris Roberts Chair, Dr Roger Aston Director; Visioneering Appoints Tom Dooley Director. May 2, Victoria Budget: May 1, April BDI Up 3. Apr 19, Royal Society Backs March For Science; Research Australia: Apr 18, Ausbiotech: Apr 12, Onji: Inhibiting HCK Reduces Gastric Cancer In Mice; Medical Developments Signs Penthrox Russia Distributor; Ansell Launches Starpharma Vivagel Condom In Canada; CSL: Innate Immunotherapeutics; Mesoblast Heart Failure Trial Interim Analysis; Apceth Drops Cancer, Retains Cynata Stem Cell Option; Genetic Signatures Launches Easyscreen STI Detection Kit; Genetic Technologies Cuts Brevagen Test Cost Mar 30, Starpharma Vivagel Bacterial Vaginosis Results By July; Prana: Mar 29, Victoria Genomics Project For Superbugs; Melbourne Uni: Mouse Neural Cells Hope For Gut Disorders; WEHI: Mar 23, Biotron: Mar 21, MIPS: Mar 15, Mesoblast: John Seaberg Chair; Wayne Paterson CEO, Director; Biotech Capital Appoints Dr Ric Degaris For Clinical Services.
Mar 13, Pharmaxis: Manoel Galvao Neto, David Cummings Advisors. David Brown, Andrew Heaton, Cristyn Humphreys Go. Mar 8, MCRI: Prof Carel Le Roux, Prof Jan Greve Advisers. Mar 2, Victoria: Feb 28, WEHI: Feb 27, Guidelines Back Nanosonics Trophon Decontamination; Orthocell: Feb 21, Takeover Panel Reasons For Innate Chris Collins Decision; Analytica: Feb 13, Mesoblast MPCs Reduce Rheumatoid Arthritis In Sheep; Correction: Jan 23, Biotech Daily: Dec 20, Redhill Doses 1st Yeliva Multiple Myeloma Patient; Zelda, Curtin Uni Trial Marijuana For Pancreatic Cancer; Factor Recruits 1st US VF Venous Leg Ulcer Patient; UK OK For Prima Aipac Imp, Paclitaxel Breast Cancer Trial; Recce: Dec 16, Multiple US States File Anti-Trust Suit Against Mayne, Others; Imugene Tells ASX: Dec 15, TGA Approves Sienna's Adjunct Bladder Cancer Test; Ellex Trains Chinese Surgeons In Itrack For Glaucoma; Resonance: Dec 9, Sirtex Tumbles Nov 25, Zelda Lodges Medical Marijuana Patents; Prima AGM Faces Nov 23, Benitec: Nov 18, Adherium Study: Nov 17, WEHI, Melbourne Uni Organoids Bank For Pancreatic Cancer; Impedimed Sozo For Heart Failure Available In ; Volpara, Microsoft Collaborate On Breast Imaging Analytics; Suda: Nov 16, CSL: Nov 14, Monash Biomedicine Discovery Institute Opens; EMA Committee Backs CSL Afstyla For Haemophilia A; Correction: Nov 10, Ellex: Nov 7, Innate: Nov 1, October BDI Down 0.
Prescient; Medadvisor To Release 2. Oct 26, Victoria: Oct 20, WEHI, Servier, Vernalis S Blocks Cancer In Mice; Proteomics To Develop Promarker Giardia Test; Avita Appoints South Africa, Benelux Distributors; Simavita Assessplus For Home Incontinence Assessment; Japan Patent For Redhill RHB Myoconda For MS; US Patent For Adherium Smartinhaler Optical Dose Counter; Medadvisor Joins Bupa-Healthscope Adherence Program; Australian Ethical Takes 5.
Oct 11, Viralytics: Sep 29, Bio-Melbourne: Melanie Farris Co Sec, Saskia Jo Finance. Sep 27, Russia Approves Pharmaxis Bronchitol For Cystic Fibrosis; Genetic Signatures Easyscreen STI Test Validation Trial. Sep 26, FDA Approval For Oventus O2vent-T, October Launch; Prescient Doses 1st Florida Breast Cancer Patient; Airxpanders: Sep 21, Bionomics: Sep 15, Resapp: Sep 14, Oncosil: Sep 12, Medical Developments: Sep 6, WEHI Studies Coeliac Disease Gluten-Free Failure, Oats Safety; Medical Developments: Aug 31, Benitec: No Calcification, No Repeat Procedures; MGC Ready For Cannabinoid Patch Human Safety Trial; Living Cell: Aug 22, Pro Medicus: Aug 10, Cellmid: Aug 3, Anteo Launches Zika, Vitamin D Tests; Three Coupling Kits; Clinuvel Completes FDA Scenesse Vitiligo Safety Study; Mach7: Jul 28, Psivida: Jul 25, MTP Connect Year Competitiveness, Productivity Plan; Correction: Jul 22, Factor Therapeutics: Jul 20, Chief Scientist: Jul 15, Psivida: Jul 14, NHMRC Top Awards For Menzies School Of Health Research; Volpara Launches Software, Hires Sales Staff; Redhill, US NIAID Collaboration On Ebola; Universal Biosensors Record H1, Q2 Sales - Cash Flow Positive; Cyclopharm Appoints Dr Michael Guo Clinical Program Head.
Jul 13, US, NZ Patents For Antisense ATL For Acromegaly; Race Opens Up Jun 30, Federal Election stocks near 200 day moving average Jun 24, UCLA Backs Genetic Signatures Enteric Pathogen Test; Bionomics Completes Phase II BNC Anxiety Trial Enrolment; Cellmid: Jun 22, Clinuvel Begins Commercial Roll-Out Of Scenesse For EPP; Prima: Jun 21, Fundamental analysis software indian stock market Prof Susan Gross Medical Director.
Jun 20, Oventus O2vent: Jun 15, China Approves All Ellex YAG Laser Treatments; Anteo, Atomo Partner For Point-Of-Care Cardiac Arrest Test; UWA Study Backs OBJ Micro-Array For Disinfection; Resonance 2-Year Unnamed Company Collaboration; Phylogica: Jun 7, Living Cell Week Data: May 31, Nanosonics: May 27, Aviragen Biota: May 26, FDA Approves CSL Afstyla For Haemophilia A; GI Dynamics Scott Schorer: May 23, ALP: May 17, WEHI Cancer Drug Action Insight To Resistance; Phosphagenics TPM-Oxycodone Mystery Japan Option; Nusep Sues Prime For GF Blood Separation Unit; Clarification: May 16, Starpharma Condoms For Rio Olympics; Regeneus Progenza Stem Cell Osteoarthritis Trial Enrolled; Nusep: May 9, Avita: May 5, Redhill Roadshow To Deepen Australian Connection; Eliminate Dengue: May forex bloomberg, Early Investor Tax Current share market price of wipro, Venture Capital Pass Senate; Avcal Details Early Stage Investor, Venture Capital Changes; Research Australia: Budget Cuts To ARC, CRCs, MRFF; Comment: Alan Hoffman, Peter Francis, Dr Ian Griffiths.
Apr 27, Victoria Budget Apr 26, Neuren: Apr 13, ITIF: Mar 31, Redhill: Opens US Office Appoints James Hattersley; Resapp Loses Director Adam Sierakowski; Medadvisor Appoints Nick England Advisor.
Mar 16, GI Dynamics To Apply To FDA For New Endobarrier Trial; CVC: Mar 10, OBJ: Mar 3, Baxalta: Feb 29, Pfizer: Sue Macleman, Bronwyn Evans, Ashley Bates; Resapp Appoints Co-Founder Brian Leedman Director. Feb 17, Mesoblast: Rodger Johnston M-D, Michael Higginson Co Sec. Feb 2, Starpharma: Jan 27, Medical Developments Penthrox Launch, Respiratory FDA OK; Living Cell: Jan 1, SPECIAL EDITION Dec 18, Osprey Data Analysis Backs Avert Reduced Kidney Damage; 3D: Dec 17, — The Year In Review; Mesoblast: Dec 16, Pharmaxis: Dec 10, CSL: Nov 27, Clarification: Nov 20, Correction: Nov 19, Editorial: Nov 13, Airxpanders Changes FDA Process To De Novo, Day Delay; Medical Australia: Nov 11, Bioxyne: Nov 4, Admedus Launches Cardiocel In Malaysia; Antisense, Strongbridge ATL Reduces Acromegaly GHBP; Bionomics: Stockbroker new york 30, OBJ: Oct 27, Monash Chancellor Dr Alan Finkel Appointed Chief Scientist; Living Cell: Oct 13, Dr Chris Nave Tells WEHI Meeting: Oct 7, High Court Rules Isolated BRCA Gene Not Patentable; Medicines Australia Concern Over IP Impact; CEO Dr Anna Lavelle Opens Ausbiotech Conference; Victoria To Build On Success; Prof Alan Trounson: Sep 28, Viralytics: Sep 23, Admedus Starts Aortic Valve Repair Trial; WEHI, ACRF Cancer Lab Opens; Singapore Approves Medical Developments Penthrox; Optiscan Takes Collaboration Halt To Suspension; Pharmaust AGM Votes On Consolidation, Dr Best Options; Biota Loses Dr Jim Fox, Gains Armando Anido, Dr Michael Dunne; Solagran Loses Ace Aim, Salim Group Director Andi Solaiman.
Sep 15, Orthocell Study Backs Cell Factory For Bone Healing; Ausbiotech Wants PM Malcolm Euronext paris trading days To Speed Tax Reform; Correction: Sep 8, Burnet: Aug 17, Mesoblast: Aug 10, Antisense: Jul 31, GI Dynamics: Optiscan; Uniquest Takes 7.
Jul 15, Mesoblast: Jul 14, Psivida: Anisina Boosts Chemo For Neuroblastoma In Mice; ITL: Jul 13, WEHI: Jul 9, Benitec Buys-Out Biomics Stake In Hepbarna For Hep B; Clarification: Jul 7, Avita Donates Recell, Staff To Taiwan Burns Victims; Acrux, Lilly Sue Lupin Over Axiron Patents; Prima: Jul 6, Vale Alastair Lucas; Avita: Jul 2, Clinuvel: Jun 30, Ausbiotech Launches Medtech Directory In China; Clarification: Lifecycle Of A Molecule.
Jun 16, Engeneic: Jun 15, Queensland Uni, Janssen Cilag Work On Inflammatory Disease; Living Cell: Jun 10, Resonance Study Backs MRI Test For Liver Fibrosis; WEHI: Jun 9, Mesoblast Claims MPC Kidney Failure Efficacy, Safety; Proteomics: Jun 2, Viralytics: May 28, Federal Government Introduces 1.
Graeme Kaufman, Martin Rogers Out - Bruce Gordon In; Prescient Appoints Moffitt Prof Said Sebti CSO; Allan Gray Reduces To Dr Jens Mikkelsen CSO, Jack Moschakis Legal, Co Sec. May 13, WEHI, Research Australia Welcome MRFF; Grant Thornton: May 8, Chiesi Adds EU To Pharmaxis Bronchitol Distribution; Polynovo Ready For Novosorb CE Mark Deep Ichimoku forex strategy Trial; Novogen: May 5, Victoria Budget: Apr 30, Starpharma: Apr 23, Melbourne University: Apr 22, Uscom: Apr 21, CSIRO, Berghofer, ANU Malaria Breath Test; WEHI: Apr 15, Cellmid Trial: Apr 13, Celgene Takes 4.
Dr Murdoch, Dr Collier, Mr Lankau Directors. Apr 7, WEHI: Mar 30, Phylogica: Mar 18, Biotech Daily Editorial: Mar 13, WEHI Edits Genomes To Kill Cancer For Its th Birthday; Universal Biosensors New Features For Siemens Test; BPH Energy: Papers Back Molecular Discovery HLSR; Agenix, Oks Resolve Thromboview Investment Case; Hunter Hall Takes 9.
Atcor; Living Cell Founder Prof Bob Elliott Steps Down As Executive; Anatara: Dr Paul Schober CEO, Damian Wilson, Paul Grujic. Feb 19, WANRI: Matthew Morgan, Frank Pertile Directors. Prof Alan Trounson, Prof Miles Prince Advisors. Feb 4, Cynata, UWA Collaborate On Stem Cells For Lung Fibrosis; Patrys: Warren Bingham, Michele Houldsworth; Phytotech To Lose Founder Ross Smith; Erlyn Dale To Co Sec; BPH Appoints Bruce Whan Director, Deborah Ambrosini Co Sec.
Jan 28, Avita Begins Pivotal Patient US Recell Burns Trial; Progen: Vale Director David Carter; Phytotech Appoints Dr Benad Goldwasser Director; Acuvax Ex-CEO Dr William Ardrey Fraud Trial Begins.
Jan 20, WANRI: Jan 19, Invion: Jan 18, SPECIAL SUMMER CATCH-UP EDITION: Jan 2, Special Edition Dec 18, - The Year In Review; Nanosonics Expands To Former Cochlear Site In Lane Cove; Genetic Technologies: Dec 16, Melbourne Uni Antibody Discovery For All-Dengue Vaccine; FDA Approves Osprey Avert Plus; Novogen: Ashwani gujral stock market 10, WEHI Welcomes Research Animal crossing city folk wii how to make bells fast Changes; Biotech Daily, Less So; Benitec: Dec 5, Monash-Led Study Shows Obesity-Leptin-Hypertension Link; Starpharma Condom Delayed Up To 6 Months In Japan; Correction: Living Cell; Prima Upgrades Patient Cell Collection Systems; Mesoblast To Release 2.
Dec 3, CSL: Dec 2, Sienna Remove stock ticker iphone 5 Bio Dec 1, November BDI Up 3. Nov 27, Labor Policy: Nov 24, Victoria State Election And State Biotechnology Policies; Genetic Technologies Dr Mervyn Jacobson Awaits Sentence; Acrux: Nov 21, Dorsavi Earns First US Revenue; Calzada: Nov 12, Neuren: Nov 7, Biotech Daily Ninth Birthday Editorial; Gaol For Phosphagenics Three - Ogru, Gianello, Jiang; Novogen: Oct 23, Bio-Melbourne: Oct 15, Federal Action Plan: Oct 14, Bionomics: Oct 7, WEHI Molecule Prevents Inflammatory Cell Death; Phosphagenics: David Carter, Dr Lindsay Wakefield Directors; Sharon Papworth Replaces Acrux CFO, Co Sec Tony Di Pietro.
Sep 19, LBT Starts Automated Plate Assessment Clinical Trials; Clinuvel Singapore J-V For Paediatric Scenesse, CUV Sep 16, David Miles Leads Review Of Cooperative Research Centres; W. Roger Aston, Silver ea forex reviews Frazer, Martin Rogers. Sep 4, Genera HPV, Respiratory Tests To TGA; STI Tests, More To Come; Reproductive Health: Aug 29, Ex-Phosphagenics CEO Dr Esra Ogru Bail Extended; Benitec TT Hepatitis C Trial: Aug 25, Orthocell: Jul 30, BRIL Group: Jul 9, All Change At QRX: Jul 1, June BDI Up 0.
Dr Jason Chaffey M-D; Joe Baini, Ron Finkel To Go. Jun 27, QRX Director Attacks EGM Board Spill Statement; Bio-Melbourne Age-Related Is forex trading a gambling Degeneration Breakfast. Jun 26, Monash Uni, Pfizer Centre For Victoria Commercialization; Neuren Completes NNZ Rett Syndrome Enrolment; Benitec: Jun 25, Avexa Reasserts Its Apricitabine ATC Program For HIV; US Trials Network Continues Mesoblast Cardiac Research; Itl Profit Warning; Mayne Completes Hedgepath Suba-iraconzaole Licence; Victoria: Bill Clinton, Bob Geldof For AIDS In Melbourne.
Jun 16, GI Dynamics Endobarrier: Jun 13, Asurequality In-Vitro Diagnostics ISO Approval; Suda Appoints Torreya For Artimist Deal; Actinogen: Jun 12, Orthocell Ortho-ATI Tendon Pain Pilot Trial: May 27, Novogen Super-Benzopyran For Prostate Cancer; Pipeline trading systems discontinues options business Supports UQ Skin Cancer Laser Detection; Imugene Appoints Bachem To Manufacture Her-Vaxx Peptide; Immuron: May 21, Phosphagenics Oxycodone Patch Relieves Pain In Horses; Immuron Appoints DB Pharm South Korea Distributor; ATP Innovations Wins Two Incubator Gongs.
May 19, Bionomics: May 16, Phosphagenics Ex-CEO Dr Esra Ogru Charged With Theft; Ex-Actinogen David Zohar 5 Months Gaol For Misleading ASX; GIDynamics: May 15, Prima: May 14, Federal Budget: May 13, Federal Government: May 12, WEHI: May 6, FDA Allows Teva Chemgenex Synribo For Home Use; GI Dynamics, GSK: May 5, Hearing CRC: Apr 24, TRI: Apr 16, Orthocell IPO For Tendon, Cartilage, Soft Tissue Repair; Drawbridge Phase I Phaxan Anaesthetic Safe, Effective; Queensland Scientists Stop Dengue With Wolbachia; Avexa, PX Biosolutions Win Victoria Technology Vouchers; US Patent For Atcor Cardiac Output Method; Analytica Requests Capital Raising Trading Halt.
Apr 9, Compumedics, US Health Trust Purchasing Agreement; Pharmaust Licences Uni Of NSW PPL-1 Cancer Drug Patent. Apr are incentive stock options taxable, WEHI: Apr 3, Correction: Apr 2, Editorial: Trials, Tribulations And Transparency; Patrys Grows Human IgM Antibody In Plants; Advanced Surgical Licences Sr-HT-Gahnite For Bone Grafts; GI Dynamics Responds To TGA Advertising Complaint; Suda Appoints 4 Experts For Artimist Expansion Trial.
Mar 27, Patrys PAT-SM6 Multiple Myeloma Results Back Combination; Reva Dumps Rezolve For Fantom, Cuts Staff; Biogrid, Genomics Health Alliance Pilot Project; Preliminary Dutch Coverage For GI Dynamics Endobarrier; Neuren AGM For 30m CFO, COO Loan Shares, 3.
Mar 26, Regeneus Register Shows Hiqcell Joint Benefit; Invion Founder, Ex-CEO Dr William Garner Reduces To Medical Australia, Bruce Hancox, Windfall. Feb 13, Actinogen Back To Antibiotic Future; Progen: Darryl Ellis COO, Bruce Hancox Director. Feb 10, FDA Clears Admedus Cardiocel For US Market; Cynata Hires Waisman For Stem Cell Manufacture; Clinuvel Starts Phase II Scenesse Hailey-Hailey Disease Trial; Uscom Wins 4-Star Central Blood Pressure Rating; Psivida H1 Revenue Up 4.
Feb 5, Acrux Tells ASX: Feb 4, WEHI: Jan 30, Mesoblast: Jan 29, ASX, Biotech Up: Jan 21, Two Phosphagenics Forex ultra scalper indicator TPM Gels For India; Psivida Loses Re-Elected American stock and transfer company llc Paul Hopper; Clarification: Psivida; Healthlinx AGM Votes For Recovery; Biotron Has Less Than Two Quarters Cash; Living Cell Loses Dr Paul Tan, Again.
Jan 2, Special Edition; Dec 13, OBJ: Jitto Arulampalam Chair, Dr Hongjen Chang Director. Nov 22, Biota Closes Antibiotic Programs; Acrux Takes Hexima Drugs For Transdermal Route; Editorial: Nov 18, IDT Files First FDA ANDA For Generic Temozolomide For Cancer; Best forex signal 2014 Nov 14, Mesoblast: AMA Raises BIS Lymphoedema Test To CPT Code 1; Acrux, Eli Lilly Sue Actavis Over Axiron Patents; Reva Rezolve2 Sales Delay, Finance, New Products Pipeline; Isonea To Lose CEO Michael Thomas In ; Thai Quoc Tang Gaol For Tissue Therapies Share Trading; Consegna AGM Votes To Become Rhinomed.
Nov 1, Adjusted 7-Year BDI Up Oct 24, Mesoblast, Intrexon, Ziopharm Unite For New Cancer Drugs; Starpharma: Oct 23, Federal Government: Oct 14, Starpharma Dendrimer-Oxaliplatin Cuts Neurotoxicity In Mice; Ellex: Oct 10, Calzada Polynovo: Oct 8, Prof Alan Cowman, Prof Lloyd Hollenberg Win Victoria Prizes; Regeneus: Oct 7, Acrux Axiron First Euro Approval, Products In Development; Ausbiotech: Oct 1, September BDI Up 3.
Sep 27, Bionomics: Sep 26, Menzies Research: Sep 23, WEHI: Sep 11, Starpharma: Unilife; Calzada Pleads Schultz To ASX Sep 3, Election Editorial: Sept 2, August BDI Down 1. Aug 27, Agenix, Arrayjet Collaborate For Micro-Array Diagnostiq; Living Cell: Kathryn Holt, Misty Jenkins, Joanne Whittaker.
Aug 22, Coalition: Aug 19, Bone: Aug 13, Patrys: Phi San Lam, Frankie Chen, Sharon Kwan. Australian Regulation Concern; Medicines Australia: Aug 2, Atcor: Jul 30, Biota CEO Russell Plumb Faces Few Australian Investors; CSIRO Decodes Barrier Reef Coral For Sunscreen; Victoria Appoints Leonie Walsh Lead Scientist; Suda Final Report: Jul 24, Phosphagenics: Jun 28, High Court Resolves CDPP V JM Artificial Price Questions; ARC Linkage Projects; Biotech Takes 4 Of 30 Commercialisation Australia Grants; Acrux: Jun 26, House Of Representatives Passes IP Amendment Bill; Mesoblast Ready For Phase II Diabetic Nephropathy Trial; Evado Launches Clinical Trial Cloud Application; GI Dynamics Appoints Al-Nozha Middle East Distributor; Fisher Funds Takes 7.
Jun 14, US Supreme Court Myriad BRCA Gene Patent Case: Complete NSW Trial Insurance Survey. May 20, WEHI: May 15, Federal Budget: Innovation Untouched; NHMRC, ARC Funding Up; Comment: May 9, High Court Reserves CDPP V JM GTG Decision; Circadian: May 8, Victoria Budget: May 1, April BDI Down 3.
Apr 19, Atcor: South African Study Backs Sphygmocor; Psivida: Apr 10, Antisense Begins Phase II ATL For Acromegaly Dosing; Patrys Completes 2nd PAT-SM6 Multiple Myeloma Cohort; Correction: Apr 9, LSQ Welcomes Federal Government McKeon Review; Novogen Isolates Most Potent Form Of CS-6; Bone BN Phase I RA Trial Equals Adalimulab At Half-Dose; Viralytics: Mar 26, John Brumby Tells Ausbiotech Summit: Mar 20, Patrys: Mar 18, European Bureaucracy Entangles Tissue Therapies, Again; Regeneus Expands To Queensland; Thorney Increases, Diluted To 5.
Feb 12, Mireven: Feb 8, Biodiem, QIMR: Feb 7, Greens, Libs Move For Science, Research Budget Protection; US, China Patents For Mesoblast Composition-Of-Matter; Reva 6-Month Follow-Up: Feb 6, Allied, CSIRO Study: Drug Exports Beat Cars, Wine; Avita Appoints Novartis V-P Director; Universal Biosensors Director Dr Colin Adam To Retire.
Feb 5, Red Cross, CSL, Bio-Melbourne: Feb 4, WEHI, Synchrotron Capture Cell Death; Alchemia Completes Phase III Ha-Irinotecan Recruitment; Bionomics BNC Enhances Rodent Episodic, Working Memory; Calzada, Polynovo Recruit Patient Novosorb Wound Trial; Circadian Nears Completion Of Phase I VGX Tumor Trial; Graham Edwards, Montoya Take 5. FDA Approves Isis, Genzyme Kynamro; Regeneus, Kolling: Jan 29, FDA Concerns On Pharmaxis Trial Design; Trading Halt; Tissue Therapies Has One Quarter Cash; Considering Options; Alchemia Loses CEO Dr Pete Smith; Uniquest Loses M-D David Henderson; Medical Developments CEO John Sharman Earns Bonus.
Jan 22, Bathurst Study: Jan 21, Medical Developments Phase III: Jan 20, Resonance Liver Fibrosis Trial: Dec 28, BDI Up 1. Dec 20, Biotech Daily: Alison Mew CEO, Ben Silluzio Director; Ex-CEO Dr Paul Tan Replaces Living Cell CSO Prof Bob Elliott. Dec 6, CSL: GI Dynamics; Eastland Promotes CEO, CFO, Looks For New Projects. Nov 30, Neuren: Nov 29, Starpharma: Nov 28, Editorial: Nov 26, WEHI: CEO David Radford 0. Nov 19, Cyclopharm Enrols 1 st Technegas Phase III Trial Patient; BPH: Novogen; Bioprospect Loses Peter May, Charles Pellegrino.
Nov 14, Prima: Nov 9, Eli Lilly Axiron Sales Fall Hits Acrux Price; Biota Takes Oct 26, Mireven Claims Preclinical Mir-7 Head, Neck Cancer Success; Nice Result: Oct 25, Neopec: Oct 24, Reva: Pharmaust; QRX AGM For k Director Options; Invion CBio AGM For 25m Director Options; Uscom AGM For 3m Executive Chairman Options.
Sep 27, CSL, Karolinska: Sep 25, Alchemia: Sep 3, August BDI Up 1. Aug 28, Spinifex Phase II Trial: Aug 15, Reva Stent Trial: Alimera Resubmits Rejected Iluvien NDA To US FDA. Cellmid; Kai Medical Sleep Treatment Backdoors Into Novogen; Uscom Has Less Than Two Quarters Cash, More Coming; Actinogen Has One Quarter Cash, More Coming; Dr Stewart Washer Replaces Isonea Chair Ross Haghighat.
Jul 13, Reva Closes Rezolve Pilot Trial — No Major Coronary Events. Jun 18, Mesoblast: Jun 14, Resmed Launches Narval Jaw Position Device; Payment Ends Nusep, Nxgen Longer Lasting Listing Litigation; Healthlinx Loses Dr Stewart Washer, Dr John Chiplin; Larry Knopf Replaces Heartware Co Sec David McIntyre; Atcor Takes Capital Raising Trading Halt To Suspension.
Jun 12, Medicines Australia To Forum: Jun 7, Verva Phase II Trial: Jun 1, May BDI Down 6. May 21, Melanoma Institute: May 9, Federal Budget: May 1, April BDI Flat, ASX Up 1.
Apr 30, UQ, Axiom Molecular Nuclear Medicine Collaboration; Correction: Breatheassist Nasal Plugs Regulator-Free. Apr 17, Pharmaxis: Apr 12, Canada Approves Acrux, Eli Lilly Axiron; Vivopharm Acquires RMIT Toxicology Testing Business; Consegna To Spin-Out Aspen Medisys; Patrys Executives US Investor Road-Show; Life Sciences Queensland Road-Show. Fill The XToll Scientific, Development Gaps. Apr 5, Cancer CRC: Mar 29, Allied Trials Adapt Pelvic Floor, Hernia Patch In Sheep; WEHI: Mar 28, Monash Uni Advances Innovation Integration Collaboration; Biota Claims Phase IIb Efficacy, Safety In Asthmatic HRV Trial; Psivida: Prof Ian Chubb On Funding.
Mar 15, CEO Interview: Mar 12, TRI: Mar 7, Novogen, Marshall Edwards IND For ME For Cancer; Michael Taylor, Peter Turvey Join Foursight; Atcor Wins US Reimbursement CPT III Code; Biotron Appoints Dr Susan Pond, Robert Thomas Directors; Psivida Appoints Heartware CEO Doug Godshall Director; Orbis Reduces To Mar 2, Gilman Wong: Feb 15, Editorial: Feb 13, Biota: Feb 9, Antisense: Journal Backs Ropren For Cognition In Rats. Feb 7, Benitec, Medistem ddRNAi-Stem Cells Treats Arthritis In Mice; Cochlear Survives Implant Recall With Record H1 Revenue; Probiomics EGM Backs Hunter Takeover, Name Change; Clinuvel Files Scenesse European Application.
Feb 1, Quiet January: Evolution And Very Intelligent Design Correction: Jan 25, Pharmaxis On Track For Bronchitol EU Sales, US Approval; Cathrx Has Two Quarters Cash, Just; Acuvax To Acquire Israeli Diagnostic; Balam Takes Jan 24, Evado Opens US Office, Appoints Maria Chiam BDM; Novogen Back In Compliance With Nasdaq. Jan 23, Sirtex: Jan 2, Dec 15, Biotech Daily: Dec 1, November BDI Down 9.
Nov 29, Regeneus Phase II Fat Stem Cell Trial For Osteoarthritis; Immuron, Hadassah Prof Ilan: Nov 15, Mesoblast: Polish Loan, Divesting Israel, China Business. Nov 1, October Good For Biotech: Oct 31, Benitec Collaboration On Rare Muscular Dystrophy; FDA Approves Circadian VGX Cancer Trials; Novogen Considers Subsidiary Share Return, Shell Sale; Living Cell AGM For 1. Oct 11, Allied Jumps Oct 7, Patrys CEO Dr Marie Roskrow: Oct 3, September BDI Down 4. Sep 28, Alchemia Claims Early Small Cell Lung Cancer Hyact Efficacy; Allied Health Requests Capital Raising Halt; WEHI: Sep 27, Patrys Year Data Backs PAT-SC1 For Gastric Cancer; CSL: Sep 22, Sunshine Heart: Sep 21, Sigma Aldrich Licences Healthlinx IGY Technology; GI Dynamics Launches Endobarrier In Austria; Clover Corp Revenue Up 0.
Sep 1, August Cruels BDI - Down Aug 25, Sirtex Revenue Up 1. Aug 18, Starpharma Swaps Condom Companies; Delay To Market; Little Dissent At Sunshine Heart EGM; Victoria Auditor-General: Cortical Dynamics IPO Extended.
Binary options - start trading binary options today. Trade and make a profit from binary options using Binomo broker.
Aug 8, WEHI, Abbott, Genentech Phase I ABT Leukaemia Trial; Medical Developments Enrols 1st UK Clinical Trial Patient; USPTO Grants Benitec Further Graham Family ddRNAi Patent; Prana Appoints Lawrence Gozlan Director.
Cash Sufficient, One-Off Costs; Benitec Relocates To Sydney, Greg West Appointed CFO.
New frontiers in pharma R&D investment | McKinsey & Company
Aug 1, July BDI Up 4. July 28, Novogen NV In Vitro Active In Resistant Cancer Stem Cells; Correction: Agenix; Stirling Loses Directors Prof Glyn Tonge, Neil Covey.
July 5, Afandin To Fund Antisense ATL Prostate Cancer Trial; Mayne Pharma Profit Warning, FDA, Doryx Rejection Hit Price; Pharmaxis Requests Formal European Re-Examination; Bioniche To Buy Plasvacc Horse, Dog Plasma Business; Bio-Melbourne: Reimbursement From Breakfast To Workshop; Stirling Takes Board, CEO, Funding Halt To Suspension. June 22, ASX, Biotech Up: June 21, NHMRC-California Call For Grant Applications; Ellex Moves Sacramento Production To Adelaide; Tissue Therapies Pays Consultant June 17, Immune System Multiple Myeloma Trial: June 8, Agenix Hoping For China Hepatitis B Trial; Bluechiip Lists On ASX Tomorrow; Europe Rejects Sigma Objection To Healthlinx Patent; Cephalon-Chemgenex Board Changes; Antisense Requests ATL, Capital Raising Trading Halt; Optiscan Appoints Cappello To Review Business; Narhex AGM To Issue 10m Options, Elect Directors; Acuvax EGM To Issue m Shares, Ratify Placement.
June 1, Pharmaxis Drags May BDI Down 3. May 20, Editorial: May 19, Lee Rodne: May 18, Bioniche Urocidin Data: May 16, Psivida: Alimera Reapplies To FDA For Iluvien For DME; Narhex, China Academy Partner On DG17 For HIV, 7. May 10, Bionomics: Cash Sufficient, Trial Costs, Capital Raising; Solagran Wins Share-Trading Apology From The Age; OMI Requests Acquisition, Capital Raising Trading Halt.
May 5, Psivida: May 4, QIMR: May 2, April BDI Up 6. Apr 27, Iroko Acquires Iceutica For Nanotechnology Delivery; Bionic Ear Institute Launches Simple, Cheap Hearing Aid; Avita Says Burns Study Backs Recell; QRX Completes Phase III Comparison Trial Enrolment; Viralytics Lodges Reply To FDA Hold Letter; Nestor Takes 6. Apr 21, PBS Committee Knocks Back Pharmaxis Bronchitol; Heartware Patient Data: Apr 18, Cellestis Board Responds To Shareholders; Heartware Patient Data: Apr 6, Ausbiotech Survey: Apr 1, March BDI Up Mar 29, Cephalon Offers 70c A Share For Chemgenex; Bioguide Brief: Mar 28, Avexa, FDA Agree ATC For HIV Path; Bioguide Brief: Mar 21, Prana: Mar 16, Prana: Mar 4, Trouble At Atec, Neopec Mills: Mar 1, February BDI Down 3.
Feb 18, WEHI: Feb 8, TGA Approves Pharmaxis Bronchitol For Cystic Fibrosis; Correction: Phase II Trial Burnt Cash, Capital Raising; Solagran Tells ASX: Legal Fees Burnt Cash, Income Expected; Barleigh Wells Ceases Substantial In Cyclopharm; IM Medical Loses Two More Directors; Stirling Requests Capital Raising Trading Halt.